In its review of tobacco-dependence treatments, the 2008 clinical practice guideline of the U.S. Public Health Service concluded, “Indeed, it is difficult to identify any other condition that presents such a mix of lethality, prevalence, and neglect, despite effective and readily available interventions.”
1 The low utilization of clinical cessation interventions by smokers and physicians alike is partly attributable to inadequate insurance coverage
1,2: many health insurers still fail to cover the evidence-based counseling and medication treatments recommended in the 2008 guideline.
2 Even when these treatments are covered, barriers to utilization such as copayments and prior-authorization requirements make obtaining them costly and inconvenient.
2 Furthermore, complex, unclear, and variable tobacco-cessation coverage can be confusing for both physicians and patients, making it harder for physicians to help patients quit smoking.
2